(Q38211737)

31 August 2017

title

Genetics, biomarkers, hereditary cancer syndrome diagnosis, heterogeneity and treatment: a review (English)

1 reference

31 August 2017

0 references

Henry T Lynch

1

1 reference

31 August 2017

Kristen Drescher

series ordinal

2

1 reference

31 August 2017

Joseph Knezetic

series ordinal

3

1 reference

31 August 2017

Stephen Lanspa

series ordinal

4

1 reference

31 August 2017

publication date

1 September 2014

1 reference

Current Treatment Options in Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

15

1 reference

31 August 2017

issue

3

1 reference

31 August 2017

page(s)

429-442

1 reference

31 August 2017

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Feasibility of screening for Lynch syndrome among patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Genetic testing in colorectal cancer: who, when, how and why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

A new model for reimbursing genome-based cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

The Cancer Genome Atlas Pan-Cancer analysis project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Translating next generation sequencing to practice: opportunities and necessary steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Differentiating Lynch-like from Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Implication of MYH in colorectal polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Morphology of sporadic colorectal cancer with DNA replication errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Genomic and epigenetic instability in colorectal cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

DNA testing and molecular screening for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Risk of cancer in cases of suspected lynch syndrome without germline mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

The mystery of mismatch repair deficiency: lynch or lynch-like?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Hereditary diffuse gastric cancer: prophylactic surgical oncology implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Decrease in mortality in Lynch syndrome families because of surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Chemotherapy of MMR-deficient colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Aspirin and folic acid for the prevention of recurrent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Personalized medicine: new genomics, old lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Increased risk of cancer in the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Ten Years After Mutation Testing for Lynch Syndrome: Cancer Incidence and Outcome in Mutation-Positive and Mutation-Negative Family Members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-014-0293-5

Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer

21 January 2018

1 reference

12 December 2020

The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer

1 reference

12 December 2020

Clinical biomarkers in colorectal cancer

1 reference

12 December 2020

The risk of gastrointestinal carcinoma in familial juvenile polyposis

1 reference

12 December 2020

Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps

1 reference

12 December 2020

Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy

1 reference

12 December 2020

A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening

1 reference

12 December 2020

Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?

1 reference

12 December 2020

1 reference

12 December 2020

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors

1 reference

12 December 2020

Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma

1 reference

12 December 2020

The role of DNA mismatch repair in platinum drug resistance

1 reference

12 December 2020

Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR

1 reference

12 December 2020

10.1007/S11864-014-0293-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1048920393

0 references

1 reference